Biomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 Diabetes.
The repurposing of biomedical data is inhibited by its fragmented and multi-formatted nature that requires redundant investment of time and resources by data scientists. This is particularly true for Type 1 Diabetes (T1D), one of the most intensely studied common childhood diseases. Intense investig...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/156a7a24928640d481d412773f7836ef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:156a7a24928640d481d412773f7836ef |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:156a7a24928640d481d412773f7836ef2021-12-02T19:57:45ZBiomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 Diabetes.1553-734X1553-735810.1371/journal.pcbi.1009382https://doaj.org/article/156a7a24928640d481d412773f7836ef2021-09-01T00:00:00Zhttps://doi.org/10.1371/journal.pcbi.1009382https://doaj.org/toc/1553-734Xhttps://doaj.org/toc/1553-7358The repurposing of biomedical data is inhibited by its fragmented and multi-formatted nature that requires redundant investment of time and resources by data scientists. This is particularly true for Type 1 Diabetes (T1D), one of the most intensely studied common childhood diseases. Intense investigation of the contribution of pancreatic β-islet and T-lymphocytes in T1D has been made. However, genetic contributions from B-lymphocytes, which are known to play a role in a subset of T1D patients, remain relatively understudied. We have addressed this issue through the creation of Biomedical Data Commons (BMDC), a knowledge graph that integrates data from multiple sources into a single queryable format. This increases the speed of analysis by multiple orders of magnitude. We develop a pipeline using B-lymphocyte multi-dimensional epigenome and connectome data and deploy BMDC to assess genetic variants in the context of Type 1 Diabetes (T1D). Pipeline-identified variants are primarily common, non-coding, poorly conserved, and are of unknown clinical significance. While variants and their chromatin connectivity are cell-type specific, they are associated with well-studied disease genes in T-lymphocytes. Candidates include established variants in the HLA-DQB1 and HLA-DRB1 and IL2RA loci that have previously been demonstrated to protect against T1D in humans and mice providing validation for this method. Others are included in the well-established T1D GRS2 genetic risk scoring method. More intriguingly, other prioritized variants are completely novel and form the basis for future mechanistic and clinical validation studies The BMDC community-based platform can be expanded and repurposed to increase the accessibility, reproducibility, and productivity of biomedical information for diverse applications including the prioritization of cell type-specific disease alleles from complex phenotypes.Samantha N PiekosSadhana GaddamPranav BhardwajPrashanth RadhakrishnanRamanathan V GuhaAnthony E OroPublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Computational Biology, Vol 17, Iss 9, p e1009382 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Biology (General) QH301-705.5 |
spellingShingle |
Biology (General) QH301-705.5 Samantha N Piekos Sadhana Gaddam Pranav Bhardwaj Prashanth Radhakrishnan Ramanathan V Guha Anthony E Oro Biomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 Diabetes. |
description |
The repurposing of biomedical data is inhibited by its fragmented and multi-formatted nature that requires redundant investment of time and resources by data scientists. This is particularly true for Type 1 Diabetes (T1D), one of the most intensely studied common childhood diseases. Intense investigation of the contribution of pancreatic β-islet and T-lymphocytes in T1D has been made. However, genetic contributions from B-lymphocytes, which are known to play a role in a subset of T1D patients, remain relatively understudied. We have addressed this issue through the creation of Biomedical Data Commons (BMDC), a knowledge graph that integrates data from multiple sources into a single queryable format. This increases the speed of analysis by multiple orders of magnitude. We develop a pipeline using B-lymphocyte multi-dimensional epigenome and connectome data and deploy BMDC to assess genetic variants in the context of Type 1 Diabetes (T1D). Pipeline-identified variants are primarily common, non-coding, poorly conserved, and are of unknown clinical significance. While variants and their chromatin connectivity are cell-type specific, they are associated with well-studied disease genes in T-lymphocytes. Candidates include established variants in the HLA-DQB1 and HLA-DRB1 and IL2RA loci that have previously been demonstrated to protect against T1D in humans and mice providing validation for this method. Others are included in the well-established T1D GRS2 genetic risk scoring method. More intriguingly, other prioritized variants are completely novel and form the basis for future mechanistic and clinical validation studies The BMDC community-based platform can be expanded and repurposed to increase the accessibility, reproducibility, and productivity of biomedical information for diverse applications including the prioritization of cell type-specific disease alleles from complex phenotypes. |
format |
article |
author |
Samantha N Piekos Sadhana Gaddam Pranav Bhardwaj Prashanth Radhakrishnan Ramanathan V Guha Anthony E Oro |
author_facet |
Samantha N Piekos Sadhana Gaddam Pranav Bhardwaj Prashanth Radhakrishnan Ramanathan V Guha Anthony E Oro |
author_sort |
Samantha N Piekos |
title |
Biomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 Diabetes. |
title_short |
Biomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 Diabetes. |
title_full |
Biomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 Diabetes. |
title_fullStr |
Biomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 Diabetes. |
title_full_unstemmed |
Biomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 Diabetes. |
title_sort |
biomedical data commons (bmdc) prioritizes b-lymphocyte non-coding genetic variants in type 1 diabetes. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/156a7a24928640d481d412773f7836ef |
work_keys_str_mv |
AT samanthanpiekos biomedicaldatacommonsbmdcprioritizesblymphocytenoncodinggeneticvariantsintype1diabetes AT sadhanagaddam biomedicaldatacommonsbmdcprioritizesblymphocytenoncodinggeneticvariantsintype1diabetes AT pranavbhardwaj biomedicaldatacommonsbmdcprioritizesblymphocytenoncodinggeneticvariantsintype1diabetes AT prashanthradhakrishnan biomedicaldatacommonsbmdcprioritizesblymphocytenoncodinggeneticvariantsintype1diabetes AT ramanathanvguha biomedicaldatacommonsbmdcprioritizesblymphocytenoncodinggeneticvariantsintype1diabetes AT anthonyeoro biomedicaldatacommonsbmdcprioritizesblymphocytenoncodinggeneticvariantsintype1diabetes |
_version_ |
1718375765026799616 |